Qtron Investments LLC Repligen Corp Transaction History

Qtron Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $366,323 - $447,060	2,145 Added 184.75%	3,306 $608,000
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $132,551 - $215,191	1,161 New	1,161 $208,000
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $295,855 - $492,474	-1,519 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $273,982 - $343,688	1,519 New	1,519 $295,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.